Switch to:
GuruFocus articles
Headlines from internet
Nov-23-17$26.13 (+0%)
08:33AMDaily Pharma Scoop Exelixis Still Attractive Portolas Bevyxxa Pluristem Patent Seekingalpha
Nov-22-17$26.13 (+0.31%)
03:40PMCabozantinib Franchise Will Continue Transform Exelixis Fortunes 2018 Seekingalpha
Nov-17-17$26.38 (+2.13%)
02:43PMExelixis Primed Excellence Seekingalpha
Nov-16-17$25.83 (+4.36%)
05:32AMMake Money Gilead Seekingalpha
Nov-12-17
09:09AMBetter Buy: Exelixis, Inc. vs. Novartis AG Fool
Nov-10-17$25.85 (+0.39%)
10:08AMEndo (ENDP) Earnings & Revenues Beat in Q3, Generics Weak Zacks
Nov-09-17$25.75 (-2.46%)
11:39AMPerrigo (PRGO) Q3 Earnings Top, 2017 View Raised, Shares Up Zacks
08:45AMMerrimack (MACK) Q3 Loss Narrower than Expected, Stock Up Zacks
08:33AMPacira (PCRX) Posts Earnings in Q3, Revenues Lag Estimates Zacks
08:30AMCatalyst (CPRX) Posts Narrower-Than-Expected Loss in Q3 Zacks
08:09AMVIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down Zacks
06:55AMAerie (AERI) Q3 Loss Wider Than Expected, Pipeline in Focus Zacks
Nov-08-17$26.4 (-0.71%)
11:21AMJazz Pharmaceuticals (JAZZ) Q3 Earnings Top, 2017 View Cut Zacks
11:16AMRegeneron (REGN) Beats on Q3 Earnings & Sales, Shares Up Zacks
10:56AMAgenus (AGEN) Reports In Line Loss in Q3, Revenues Lag Zacks
09:12AMInfinity (INFI) Q3 Loss Narrower than Expected, View Intact Zacks
09:07AMAVEO Pharmaceuticals Q3 Loss Narrows, Focus on Fotivda Zacks
08:53AMArena Pharmaceuticals (ARNA) Q3 Loss Widens Y/Y, Sales Beat Zacks
Nov-06-17$27.38 (+4.3%)
03:01PMExelixis Inc 2017 Q3 Results Earnings Call Slides Seekingalpha
02:56PMExelixis, Inc. Looks Ahead -- but the 3rd Quarter Wasn't Too Shabby Fool
Nov-03-17$26.25 (+2.86%)
01:22PMSpectrum (SPPI) Earnings, Sales Beat Q3 Estimates Zacks
11:08AMAchillion (ACHN) Q3 Loss Narrows, Pipeline Expansion in Focus Zacks
09:25AMAveo Pharmaceuticals Buy Dip Seekingalpha
09:23AM3 Reasons Behind Exelixis Stock's Big Bounce Fool
08:21AMRadius Health (RDUS) Earnings Miss in Q3, Tymlos in Focus Zacks
Nov-02-17$25.52 (+5.32%)
04:04PMThe Clear Reason Exelixis, Inc. Rocketed Higher by as Much as 10% Fool
11:08AMAgios (AGIO) Q3 Loss Narrower than Expected, Revenues Up Y/Y Zacks
10:27AMZoetis (ZTS) Beats on Q3 Earnings & Sales, Ups 2017 View Zacks
10:10AMGeron (GERN) Q3 Loss Narrower Than Expected, Sales Miss Zacks
09:36AMExelixis (EXEL) Beats Q3 Earnings on Solid Cabometyx Sales Zacks
09:19AMConatus (CNAT) Loss Wider Than Expected in Q3, Sales Miss Zacks
09:15AMSucampo (SCMP) Beats on Q3 Earnings & Revenues, Ups '17 View Zacks
09:02AMIntercept (ICPT) Q3 Loss Narrower Than Expected, Sales Beat Zacks
04:31AMExelixis Strong Earnings Coupled Promising Prospects Seekingalpha
Nov-01-17$24.23 (-2.26%)
01:58PMAcorda (ACOR) Q3 Earnings Lag Estimates, Revenues Up Y/Y Zacks
Oct-31-17$24.79 (-4.95%)
07:34AMIf Celgene Buys This Biotech, Investors Should Win Big-Time Fool
Oct-30-17$26.08 (-2.07%)
10:53AMShire (SHPG) Q3 Earnings Beat, Immunology Franchise Strong Zacks
Oct-27-17$26.63 (+2.74%)
12:05PMWhat's in the Offing for Exelixis (EXEL) in Q3 Earnings? Zacks
Oct-26-17$25.92 (+0.12%)
10:41AMBristol-Myers (BMY) Misses on Q3 Earnings, Opdivo in Focus Zacks
Oct-25-17$25.89 (-2.08%)
11:32AMExelixis Stock Looks Promising Despite High Valuation Multiples Seekingalpha
Oct-24-17$26.44 (-2%)
08:16AM3 Top Biotech Stocks to Buy Now Fool
Oct-23-17$26.98 (-0.7%)
07:38AMExelixis Elucidating Ramifications Celestial Trial Seekingalpha
Oct-21-17
10:48AMBetter Buy: Exelixis, Inc. vs. Intra-Cellular Therapies Inc. Fool
Oct-20-17$27.17 (-1.06%)
04:28PMCancer Treatment Update: Second Gene Therapy Receives Approval Zacks
Oct-19-17$27.46 (-0.25%)
10:01AMBiotech Developer Stocks Best Wealth Builders Now Seekingalpha
Oct-18-17$27.53 (-2.72%)
12:48PMDaily Pharma Scoop Azns Imfinzi Sbla Ablynx U S Ipo Teva Buy Seekingalpha
09:00AM3 Things Biotech Learn Today October 18 2017 Seekingalpha
06:32AMBiotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug Zacks
Oct-17-17$28.3 (-2.48%)
11:28AMDaily Pharma Scoop Everybodys Gilead Problem Halozymes Progress Ziopharms Gene Therapy Seekingalpha
09:03AMCompany News For Oct 17, 2017 Zacks
09:00AM3 Things Biotech Learn Today October 17 2017 Seekingalpha
08:18AMWhy Exelixis' Rebound Is Just Getting Started Fool
08:15AMFDA Grants Priority Review for Exelixis' RCC Drug Cabomteyx Zacks
07:33AMExelixis (EXEL) Looks Good: Stock Adds 17.2% in Session Zacks
04:36AMBiotech Analysis Central Daily Pharma News October 17 2017 Seekingalpha
Oct-16-17$29.02 (+17.21%)
05:04PMWhat Happened in the Stock Market Today Fool
04:12PMRecords for Wall Street as Apple Gains Offset Healthcare Slide theStreet
01:04PMBiotech Forum Daily Digest Aratana Therapeutics Back Spotlight Seekingalpha
12:57PMWhy Exelixis, Inc. Rose Higher Today Fool
11:42AMWall Street on Track to Close at Fresh Records as Energy Rises theStreet
09:34AMStocks Tiptoe Higher as Crude Oil Tops $52 theStreet
07:26AMExelixis shares surge 19% premarket after FDA grants priority review to kidney cancer drug MarketWatch
07:19AMExelix shares surge 19% premarket after FDA grants priority review to kidney cancer drug MarketWatch
Sep-28-17$24.23 (+2.02%)
12:08PMBiotech Developer Stocks Now Best Wealth Builders Seekingalpha
Sep-26-17$23.59 (+1.03%)
06:25AMDaily Pharma Scoop Alnylams Big Win Aradigm Nda Rating Exel Azn Japan Expansions Seekingalpha
Sep-23-17
07:30AMBiotech Big Payoff Seekingalpha
Sep-19-17$27.92 (+1.23%)
07:28AMWill Federal Reserve Send Market Higher Seekingalpha
Sep-17-17
08:00AM3 Things Biotech Learn Today September 17 2017 Seekingalpha
Sep-11-17$26.24 (+1.04%)
04:57PMWeekly Pharma Scoop Valeants Crl Resolution Eagle Undervalued Array Positive Results Seekingalpha
Aug-29-17$27.56 (+0.88%)
08:00AM3 Things In Biotech You Should Learn Today: August 29, 2017 Seekingalpha
Aug-18-17$26.33 (-2.05%)
12:36PMBiotech Forum Daily Digest: What's Next For Adamas Pharmaceuticals? Seekingalpha
Aug-17-17$26.88 (+0.37%)
11:00AMExelixis: Time To Reach The Top Seekingalpha
Aug-16-17$26.78 (-0.48%)
06:43PM3 Things In Biotech You Should Learn Today: August 17, 2017 Seekingalpha
12:03PMOpdivo's Renal Failure Boosts Exelixis - Or Does It? Seekingalpha
11:18AMBiotech Forum Daily Digest: Revisiting Bellicum Pharmaceuticals Seekingalpha
Aug-12-17
09:00AM3 Things In Biotech You Should Learn Today: August 12, 2017 Seekingalpha
Aug-04-17$26.66 (+3.7%)
09:58AMExelixis Earnings: Did The Market Respond Appropriately? Seekingalpha
Jul-18-17$26.15 (-0.23%)
06:37AMTableau Software Is On Fire - Cramer's Lightning Round (7/17/17) Seekingalpha
Jul-17-17$26.21 (-1.98%)
02:33PMUpdates To Exelixis Thesis: Management Continues To Execute Seekingalpha
Jul-14-17$26.74 (+0.6%)
09:45AMIntegrated BioSci Investing Launched: Exclusive Intelligence And Consulting From Dr. Tran Seekingalpha
Jul-12-17$26.61 (+4.68%)
09:55AM3 Things In Biotech You Should Learn Today: July 12, 2017 Seekingalpha
Jul-10-17$25.49 (+1.11%)
12:20PMBiotech Forum Daily Digest - IPO Activity Increasing, Spotlight On Flexion Therapeutics Seekingalpha
Jul-06-17$24.6 (-1.48%)
10:53AMExelixis: Great Stock, What's Next? Seekingalpha
06:33AMParker-Hannifin Can Reach $200 - Cramer's Lightning Round (7/5/17) Seekingalpha
Jul-01-17
12:54AMBiotech Stocks: Renewed Price Interest By Market-Maker Clients Seekingalpha
Jun-29-17$24.64 (+2.58%)
04:56PMAcadia Pharmaceuticals: Biotech Stocks In Renewed Price Interest Seekingalpha
Jun-21-17$24.02 (+7.81%)
08:23AM3 Things In Biotech You Should Learn Today: June 21, 2017 Seekingalpha
May-15-17$21.7 (+0.42%)
05:23PMGilead: Dead Money, Time For Investors To Move On Seekingalpha
May-04-17$22.04 (-2.13%)
01:16PMBest Biotech Stocks For Capital Gains In The Next 3 Months Seekingalpha
May-02-17$23.16 (+0.04%)
03:53PMCytRx's Controversial Saga Continues Seekingalpha
03:33PMIs There More Upside? Edition 2 Seekingalpha
May-01-17$23.15 (+3.35%)
05:09PMExelixis, Inc. 2017 Q1 - Results - Earnings Call Slides Seekingalpha
Apr-18-17$20.88 (-1.93%)
02:02PMA Dry Run For Novartis And Allergan's Liver Disease Assets Seekingalpha
Dec-31-69
07:00PMExelisis Soars After FDA Grants Priority Review for Kidney Cancer Drug theStreet
07:00PMExelisis Soars After FDA Grants Priority Review for Kidney Cancer Drug theStreet
07:00PMExelisis Pops as FDA Gives Kidney Cancer Drug Priority Review -- Biotech Movers theStreet
07:00PMExelisis Pops as FDA Gives Kidney Cancer Drug Priority Review -- Biotech Movers theStreet
07:00PMExelixis Pops as FDA Gives Kidney Cancer Drug Priority Review -- Biotech Movers theStreet
07:00PMExelixis Pops as FDA Gives Kidney Cancer Drug Priority Review -- Biotech Movers theStreet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK